Literature DB >> 3517168

Complement effects on the infectivity of Plasmodium gallinaceum to Aedes aegypti mosquitoes. I. Resistance of zygotes to the alternative pathway of complement.

C A Grotendorst, R Carter, R Rosenberg, L C Koontz.   

Abstract

Gametocytes are the intraerythrocytic stages of malaria parasites that infect mosquitoes. When gametocytes of the chicken malaria parasite Plasmodium gallinaceum are ingested by a mosquito they become extracellular in the mosquito midgut, form gametes, and fertilize within 10 to 15 min after the insect has taken a blood meal. Gametocytes of P. gallinaceum were infectious when fed to Aedes aegypti mosquitoes in blood meals containing native serum from chickens or from the non-host species, man or sheep. Gametocytes stimulated to undergo gametogenesis and to fertilize in vitro were also infectious when fed to mosquitoes in native chicken serum. However, native serum from most non-host species, including sheep and man, suppressed the infectivity of newly fertilized zygotes to mosquitoes and lysed the zygotes in vitro. These effects were shown to be due to the activity of the alternative pathway of complement (APC) in the serum of the non-host species. After mild trypsin treatment, the zygotes of P. gallinaceum no longer infected mosquitoes in the presence of native chicken serum, although in heat-inactivated chicken serum their infectivity was normal. We conclude that trypsin-sensitive components on the zygotes surface protect them from destruction by the APC of their native host. The ability of gametocytes of P. gallinaceum to infect mosquitoes in the presence of native human serum is probably due to proteases that inactivate the APC of human serum before the gametes and zygotes emerge as extracellular parasites in the blood meal.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3517168

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  10 in total

1.  P25 and P28 proteins of the malaria ookinete surface have multiple and partially redundant functions.

Authors:  A M Tomas; G Margos; G Dimopoulos; L H van Lin; T F de Koning-Ward; R Sinha; P Lupetti; A L Beetsma; M C Rodriguez; M Karras; A Hager; J Mendoza; G A Butcher; F Kafatos; C J Janse; A P Waters; R E Sinden
Journal:  EMBO J       Date:  2001-08-01       Impact factor: 11.598

2.  Interaction between host complement and mosquito-midgut-stage Plasmodium berghei.

Authors:  G Margos; S Navarette; G Butcher; A Davies; C Willers; R E Sinden; P J Lachmann
Journal:  Infect Immun       Date:  2001-08       Impact factor: 3.441

Review 3.  Malaria transmission blocking immunity and sexual stage vaccines for interrupting malaria transmission in Latin America.

Authors:  Myriam Arévalo-Herrera; Yezid Solarte; Catherin Marin; Mariana Santos; Jenniffer Castellanos; John C Beier; Sócrates Herrera Valencia
Journal:  Mem Inst Oswaldo Cruz       Date:  2011-08       Impact factor: 2.743

Review 4.  Determinants of Malaria Transmission at the Population Level.

Authors:  Teun Bousema; Chris Drakeley
Journal:  Cold Spring Harb Perspect Med       Date:  2017-12-01       Impact factor: 6.915

Review 5.  Family members stick together: multi-protein complexes of malaria parasites.

Authors:  Andrea Kuehn; Nina Simon; Gabriele Pradel
Journal:  Med Microbiol Immunol       Date:  2010-04-24       Impact factor: 3.402

Review 6.  Evaluation of the Pfs25-IMX313/Matrix-M malaria transmission-blocking candidate vaccine in endemic settings.

Authors:  Charles Mulamba; Chris Williams; Katharina Kreppel; Jean Bosco Ouedraogo; Ally I Olotu
Journal:  Malar J       Date:  2022-06-02       Impact factor: 3.469

7.  Murine complement reduces infectivity of Plasmodium yoelii to mosquitoes.

Authors:  T Tsuboi; Y M Cao; M Torii; Y Hitsumoto; H Kanbara
Journal:  Infect Immun       Date:  1995-09       Impact factor: 3.441

8.  The Plasmodium bottleneck: malaria parasite losses in the mosquito vector.

Authors:  Ryan C Smith; Joel Vega-Rodríguez; Marcelo Jacobs-Lorena
Journal:  Mem Inst Oswaldo Cruz       Date:  2014-08       Impact factor: 2.743

9.  Transmission blocking potency and immunogenicity of a plant-produced Pvs25-based subunit vaccine against Plasmodium vivax.

Authors:  A M Blagborough; K Musiychuk; H Bi; R M Jones; J A Chichester; S Streatfield; K A Sala; S E Zakutansky; L M Upton; R E Sinden; I Brian; S Biswas; J Sattabonkot; V Yusibov
Journal:  Vaccine       Date:  2016-05-10       Impact factor: 3.641

Review 10.  Immunity against sexual stage Plasmodium falciparum and Plasmodium vivax parasites.

Authors:  Roos M de Jong; Surafel K Tebeje; Lisette Meerstein-Kessel; Fitsum G Tadesse; Matthijs M Jore; Will Stone; Teun Bousema
Journal:  Immunol Rev       Date:  2019-12-16       Impact factor: 12.988

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.